What is the EU Joint Clinical Assessment (JCA) and what does it mean for market access and reimbursment in Euorpe?
Read More
We are delighted to announce that the second edition of our popular introductory guide: ‘Market access and reimbursement in key European markets’ is now available. Our market access experts have...
Read More
We’re delighted to announce that we will be exhibiting at ISPOR Europe in Copenhagen over the 13th–15th November 2023. Visit our virtual booth Meet the team Research & Posters Meet...
Read More
For our Global Whispers webinar in October, Clare Foy (Director – Global Market Access, Mtech Access) spoke to Italian market access expert Prof. Fabrizio Gianfrate (Professor of Health Economics and...
Read More
What is an AMCP dossier and how are they used in US market access? Drawing on their extensive experience compiling AMCP dossiers, here, our global market access experts explain when, why and how…
On Wednesday 16th August Calum Jones (Senior Consultant – Health Economics, Mtech Access) spoke to Dr George Magrath (CEO, Lexitas) about the use of AI in clinical trials, where and...
Read More
How can you ensure that the market access materials, value proposition and evidence developed by global teams, will resonate for your local audience? In this article, our experts pool their knowledge to share their top tips for successfully taking global materials local.
Our global market access experts have put together this framework of activities for successful market access. Download the PDF summary.
In this webinar, we explore market access challenges in Germany, Austria and Switzerland. Clare Foy (Global Market Access Director – Mtech Access) speaks to Dr Stefan Walzer (CEO, President &...
Read More
Reflections, highlights and key takeaways from the MedTech Forum 2023
